HIV ile Yaşayan Kişilerde Yaşam Kalitesi, Anksiyete ve Depresyonun Değerlendirilmesi
PDF

ÖZGÜN MAKALE

HIV ile Yaşayan Kişilerde Yaşam Kalitesi, Anksiyete ve Depresyonun Değerlendirilmesi

Mediterr J Infect Microb Antimicrob 2024;13:19-19 DOI: 10.4274/mjima.galenos.2024.23078.19
, , , ,
PDF
İzin

Öz

Giriş

Antiretroviral tedavilerdeki ilerlemeler ve insan immün yetmezlik virüsü ile yaşayan kişilerde (HİYK) beklenen yaşam süresindeki artışla birlikte, sağlıkla ilişkili yaşam kalitesi (SİYK) giderek daha önemli bir konu haline gelmiştir. Bu çalışmada, HİYK’de anksiyete, depresyon ve SİYK’yi belirlemeyi amaçladık.

Gereç ve Yöntem

Bu çalışma; Mart - Kasım 2020 tarihleri arasında Türkiye’deki bir 3. basamak hastane olan Mersin Üniversitesi Hastanesi’nde gerçekleştirilmiş olup 208 HİYK ve 100 sağlıklı birey çalışmaya katılmıştır. SİYK, Kısa Form-36 (SF-36) kullanılarak, depresyon ve anksiyete ise sırasıyla Beck Depresyon Ölçeği (BDÖ) ve Beck Anksiyete Ölçeği (BAÖ) kullanılarak değerlendirilmiştir. Univariate analiz sonuçlarına göre p değeri <0,25 olan ve klinik olarak SF-36 fiziksel bileşen skoru (FBS) ve mental bileşen skoru (MBS) üzerinde risk etmeni olabilecek tüm aday değişkenler seçilerek multivarite lojistik regresyon analizi ile değerlendirildi.

Bulgular

İnsan immün yetmezlik virüsü ile yaşayan kişilerde FBS ve MBS anlamlı derecede düşük (p<0,05), BDÖ ve BAÖ skorları ise anlamlı derecede yüksekti (p<0,05). Depresyon ve anksiyete oranları sırasıyla %31,7 ve %22,1 idi. Anksiyete ve depresyon yaşam kalitesini olumsuz yönde etkilemişti (p<0,05). Multivarite analiz sonucuna göre, kadın cinsiyet [FBS için p=0,040, odds oranı (OR): 3,115, %95 güven aralığı (CI): 0,109-0,949; MBS için p=0,033, OR: 4,200, %95 CI: 0,063-0,893], poliklinik kontrollerine gelmeme (FBS için p=0,025, OR: 2,397, 95% CI: 1,114-5,159; MBS için p=0,017, OR: 3,407, 95% CI: 1,250-9,282), depresyon (FBS için p=0,001, OR: 3,479, %95 CI: 1,612-7,508; MCS üzerindeki risk hesaplanamamıştır) ve anksiyete (FBS için p=0,042, OR: 2,597, 95% CI: 1,035-6,518; MBS için p=0,001, OR: 6,745, 95% CI: 2,153-21,124) hem düşük FBS hem de MBS ile ilişkili faktörlerdir.

Sonuç

Çalışmamızda, HİYK’de anksiyete ve depresyon düzeyleri yüksekti ve SİYK üzerinde olumsuz etkisi olmaktadır.

Anahtar Kelimeler: Anksiyete, depresyon, insan immün yetmezlik virüsü, AIDS, sağlıkla ilişkili yaşam kalitesi

Kaynakça

1

UNAIDS. Fact Sheet 2022. Last Accessed Date: 2022 Jan 13. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf

2

Republic of Turkey, Ministry of Health. HIV-AIDS İstatistikleri. Last Accessed Date: 2022 Sep 13. Available from: https://hsgm.saglik.gov.tr/depo/birimler/bulasici-hastaliklar-ve-erken-uyari-db/Dokumanlar/Istatistikler/hiv-aids-2023.pdf

3

Carballo E. UNAIDS Global HIV Statistics. Last Accessed Date: 2022 Jan 13. Available from: https://www.unaids.org/en/resources/fact-sheet

4

Cooper V, Clatworthy J, Harding R, Whetham J. Emerge Consortium. Measuring quality of life among people living with HIV: a systematic review of reviews. Health Qual Life Outcomes. 2017;15:220.

5

Pedersen KK, Eiersted MR, Gaardbo JC, Pedersen M, Gerstoft J, Troseid M, Nielsen SD. Lower Self-Reported Quality of Life in HIV-Infected Patients on cART and With Low Comorbidity Compared with Healthy Controls. J Acquir Immune Defic Syndr. 2015;70:16-22.

6

Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, Anderson J, Collins S, Hart G, Sherr L, Lampe FC. ASTRA (Antiretrovirals, Sexual Transmission and Attitudes) Study: Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV. 2014;1:32-40.

7

Lazarus JV, Safreed-Harmon K, Barton SE, Costagliola D, Dedes N, Del Amo Valero J, Gatell JM, Baptista-Leite R, Mendão L, Porter K, Vella S, Rockstroh JK. Beyond viral suppression of HIV-the new quality of life frontier. BMC Med. 2016;14:1-5.

8

World Health Organization. Measuring quality of life: the development of the World Health Organization Quality of Life Instrument (WHOQOL). Geneva. 1993.

9

Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality-of-life claims for labeling and promotion. Value Health. 1999;2:113-27.

10

Bowling A. Measuring disease: A review of disease-specific quality of life measurement scales. 2nd ed. Berkshire: Open University Press; 2001.

11

Popping S, Kall M, Nichols BE, Stempher E, Versteegh L, van de Vijver DAMC, van Sighem A, Versteegh M, Boucher C, Delpech V, Verbon A. Quality of life among people living with HIV in England and the Netherlands: a population-based study. Lancet Reg Health Eur. 2021;8:100177.

12

Kall M, Fresán U, Guy D, Brown G, Burgui C, Castilla J, Grecu VI, Dumitrescu F, Delpech V, Lazarus JV. Quality of life in people living with HIV in Romania and Spain. BMC Infect Dis. 2021;21(Suppl 2):898.

13

Erdinc FS, Dokuzoguz B, Unal S, Komur S, Inkaya AC, Inan D, Karaoglan I, Deveci A, Celen MK, Kose S, Erben N, Senturk GC, Heper Y, Kutlu SS, Hatipoglu CA, Sumer S, Kandemir B, Sirmatel F, Bayindir Y, Yilmaz E, Ersoy Y, Kazak E, Yildirmak MT, Kayaaslan B, Ozden K, Sener A, Kara A, Gunal O, Birengel S, Akbulut A, Yetkin F, Cuvalci NO, Sargin F, Pullukcu H, Gokengin D, Multicentric Hiv Study Group. Temporal Trends in the Epidemiology of HIV in Turkey. Curr HIV Res. 2020;18:258-66.

14

Gokengin D, Tabak F, Korten V, Lazarus JV, Unal S. The HIV Treatment Cascade in Turkey. HepHIV 2019 Bucharest Conference: Challenges of Timely and Integrated Testing and Care. 2019;P04/09. Available from: https://eurotest.org/media/usumqenv/po4_09.pdf

15

Gokengin D, Cimen C, Cagatay A, Gencer S, Akalin H, Ceran N, Deveci A, Ozdemir H, Erdinc S, Dogan G, Korten V. HIV cascade of care in Turkey: Data from the HIV-TR cohort. HIV Med. 2019;20:112-3.

16

Kuman Tunçel Ö, Pullukçu H, Erdem HA, Kurtaran B, Taşbakan SE, Taşbakan M. COVID-19-related anxiety in people living with HIV: an online cross-sectional study. Turk J Med Sci. 2020;50:1792-800.

17

Karacaer Z, Altındiş S, Gencer S, Gümüşer F, Erol S, Özkan H, Öztürk S, Birengel S, Parlak E, Yalçı A, Ağalar C, Tosun S, Altındiş M. Quality of life in people living with human immunodeficiency virus: A cross-sectional study. Klimik Derg. 2019;32:154-60.

18

Atalay S, Ucak HA, Ascibasi K, Sonmez U. Quality of Life of People Living with HIV Compared with that of The General Population in Turkey: A Cross Sectional Study. PBS. 2022;12:32-40.

19

Demirel OF, Mayda PY, Yıldız N, Sağlam H, Koçak BT, Habip Z, Kadak MT, Balcıoğlu İ, Kocazeybek B. Self-stigma, depression, and anxiety levels of people living with HIV in Turkey. Eur J Psychiat. 2018;32:182-6.

20

Ergen P, Görmez A, Ankaralı H, Aydın Ö, Baysal NB, Çağ Y. Anxiety and Depression among People Living with HIV During the COVID-19 Pandemic: A Face-to-Face Survey from Turkey. Psychiatr Danub. 2023;35:103-11.

21

Aşçıbaşı K, Albayrak Uçak H, Atalay S, Sönmez U. Depressive and Anxiety Symptoms Among People Living with HIV in Turkey: A Cross-sectional Study. J Tepecik Educ Res Hosp. 2022;32:63-72.

22

Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473-83.

23

Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality‐of‐life instruments. Pharmacoeconomics. 2000;17:13-35.

24

Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1. Health Qual Life Outcomes. 2007;5:54.

25

Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171-8.

26

Hikasa S, Shimabukuro S, Hideta K, Kuroda N, Higasa S, Sawada A, Tokugawa T, Ikegami A, Kotani A, Kimura T. Quality of life of people living with HIV compared with that of the general population in Japan. J Infect Chemother. 2017;23:698-702.

27

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.

28

Hisli N. Beck Depresyon Envanterinin üniversite öğrencileri için geçerliği, güvenirliği. Psikoloji Dergisi. 1989;7:3-13.

29

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893-7.

30

Ulusoy M, Sahin NH, Erkmen H. (1998). Turkish version of the beck anxiety inventory: Psychometric properties. Journal of Cognitive Psychotherapy. 12;2:163-172. Retrieved from: https://www.proquest.com/scholarly-journals/turkish-version-beck-anxiety-inventory/docview/205853806/se-2

31

Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corp. 1993.

32

Bekele T, Rourke SB, Tucker R, Greene S, Sobota M, Koornstra J, Monette L, Rueda S, Bacon J, Watson J, Hwang SW, Dunn J, Guenter D. Positive Spaces Healthy Places Team. Direct and indirect effects of perceived social support on health-related quality of life in persons living with HIV/AIDS. AIDS Care. 2013;25:337-46.

33

Mengistu N, Hareru HE, Shumye S, Yimer S, Sisay D, Kaso AW, Muche T, Kassaw C, Soboksa NE, Molla W, Molla A, Duko B. Health related quality of life and its association with social support among people living with HIV/AIDS receiving antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. Health Qual Life Outcomes. 2022;20:77.

34

Barger D, Hessamfar M, Neau D, Farbos S, Leleux O, Cazanave C, Rouanes N, Duffau P, Lazaro E, Rispal P, Dabis F, Wittkop L, Bonnet F. Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study). Sci Rep. 2023;13;16535.

35

Nobre N, Pereira M, Roine RP, Sintonen H, Sutinen J. Factors associated with the quality of life of people living with HIV in Finland. AIDS Care. 2017;29:1074-8.

36

Briongos Figuero LS, Luque PB, Martin TP, Sagrado MG, Bouza JME. Assessment of factors influencing health-related quality of life in HIV-infected patients. HIV Med. 2011;12:22-30.

37

Brown GR, Rundell JR, McManis SE, Kendall SN, Zachary R, Temoshok L. Prevalence of psychiatric disorders in early stages of HIV infection. Psychosom Med. 1992;54:588-601.

38

Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, Dehnad A, Aryankhesal A, Shabaninejad H, Ghasemyani S, Alihosseini S, Bragazzi NL, Raoofi S, Kiaee ZM, Ghashghaee A. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019;9:404-12.

39

Fumaz CR, Larrañaga-Eguilegor M, Mayordomo-López S, Gómez-Martínez S, González-García M, Ornellas A, Fuster Ruiz de Apodaca MJ, Remor E, Ballester-Arnal R. Spanish Group for the Quality of Life Improvement in HIV or AIDS. Health-related quality of life of people living with HIV infection in Spain: a gender perspective. AIDS Care. 2019;31:1509-17.

40

Belak Kovacević S, Vurusić T, Duvancić K, Macek M. Quality of life of HIV-infected persons in Croatia. Coll Antropol. 2006;(30 Suppl 2):79-84.

41

Perez IR, Lima AODL, del Castillo LS, Bano JR, Ruz MAL, Jimenez AD. No differences in quality of life between men and women undergoing HIV antiretroviral treatment: Impact of demographic, clinical and psychosocial factors. Aids Care. 2009;21:943-52.

42

Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, Grant I, Woods SP; HIV Neurobehavioral Research Program HNRP Group. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS. 2013;27:5-16.

43

Hays RD, Cunningham WE, Sherbourne CD, Wilson IB, Wu AW, Cleary PD, McCaffrey DF, Fleishman JA, Crystal S, Collins R, Eggan F, Shapiro MF, Bozzette SA. Health-related quality of life in patients with human immunodefciency virus infection in the United States: result from the HIV cost and services utilization study. Am J Med.2000;108:714-22.

44

Liu H, Zhao M, Ren J, Qi X, Sun H, Qu L, Yan C, Zheng T, Wu Q, Cui Y. Identifying factors associated with depression among men living with HIV/AIDS and undergoing antiretroviral therapy: a crosssectional study in Heilongjiang, China. Health Qual Life Outcomes. 2018;16:190.

45

Beyene Gebrezgiabher B, Huluf Abraha T, Hailu E, Siyum H, Mebrahtu G, Gidey B, Abay M, Hintsa S, Angesom T. Depression among adult HIV/AIDS patients attending ART clinics at Aksum Town, Aksum, Ethiopia: a cross-sectional study. Depression Res Treat. 2019;2019:3250431.

46

Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, Gibert CL, Butt AA, Justice AC. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20:1142-5.